Navigation Links
Origin Agritech Limited Reports Unaudited First Quarter Financial Results For Three Months Ended December 31, 2012
Date:2/5/2013

December 31, 2012 was RMB11.9 million (US$1.9 million), up 9.2% from RMB10.9 million in the same period of the prior year.

Total operating expenses for the first quarter ended December 31, 2012 were RMB34.1 million (US$5.4 million), representing a 23.5% decrease from the RMB 44.6 million reported for the same period in 2011. The corporate restructuring, as discussed in the Company's 20-F filing with SEC, has led to lower operating expenses. Selling and marketing expenses were RMB16.8 million (US$2.7 million) for the first quarter of fiscal 2013, a decrease of 7.7% from RMB18.2 million for the same period last year mainly due to lower transportation costs. General and administrative expenses were RMB12.6 million (US$2.0 million) for the first quarter ended December 31, 2012, down 36.4% from RMB19.8 million one year ago. The decline was mainly due to the expense control measures adopted since last year. Research and development expenses increased to RMB10.1 million (US$1.6 million) in the first quarter of fiscal 2013 from RMB7.7 million for the same quarter last year, mainly due to higher staff compensation and addition of research personnel during this period.

Operating loss for the first quarter of fiscal 2013 decreased to RMB22.2 million (US$3.5 million) from an operating loss of RMB 33.8 million for the same period in fiscal 2012.

Net loss for the first quarter of fiscal 2013 decreased to RMB23.0 million (US$3.7 million), or net loss per share of RMB0.98 (US$0.16), from a net loss of RMB34.5 million, or net loss per share of RMB1.48 in the same period one year ago.

BALANCE SHEETAs of December 31, 2012, cash and cash equivalents were RMB222.8 million (US$35.4 million) and shareholders' equity was RMB239.3 million (US$38.1 million). The Company had short-term loans of RMB153.0 million (US$24.3 million) and long-term borrowing of RMB56.0 million (US$8.9 million). Short-term loans were mainly for the working capital, while long-term borro
'/>"/>

SOURCE Origin Agritech Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Strange cousins: Molecular alternatives to DNA, RNA offer new insight into lifes origins
2. Origin Agritech Limited to Announce FY2012 Third Quarter Financial Results on August 7
3. Origin Agritech Limited Reports Unaudited Third Quarter Financial Results For Three Months Ended June 30, 2012
4. The original Twitter? Tiny electronic tags monitor birds social networks
5. Ansell Limited Expands Korean Presence
6. Customer Satisfaction, A key to Success: Narang Medical Limited
7. China Cord Blood Corporation and Cordlife Group Limited Foster Closer Alliance Across Asia
8. China Cord Blood Corporation and Golden Meditech Holdings Limited Enter into Convertible Note Financing to Further Expand Cord Blood Banking Services
9. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
10. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
11. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MESA, Calif. , July 24, 2014  Now ... close to home. Rehealth Regenerative Therapies , located ... athletes and other physically active people a new health ... Regardless of age, countless patients suffer from ... sport activities, such as muscle tears, torn rotator cuff, ...
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... biotechnology company in the emerging field of regenerative ... live webcast of a presentation to investors on ... 1:30 p.m. PDT.  The presentation will include an ... pipeline. To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... , July 24, 2014  ECC West Africa, LLC ... with University College Hospital (UCH) Ibadan Board ... project to finance, design, construct, and operate and maintain ... Nigeria . Under the first of the 4-phase ... documents and funding applications. UCH Ibadan intends to finance ...
(Date:7/24/2014)... sophisticated equipment, trained personnel, and detection dogs to ... attacks. A revolutionary new electronic chip with nano-sized ... much easier. , The groundbreaking nanotechnology-inspired sensor, devised ... ,s School of Chemistry and Center for Nanoscience ... Tracense, picks up the scent of explosives molecules ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2Nano-sized chip 'sniffs out' explosives far better than trained dogs 2
... 2008 at 9:30 a.m., SUNRISE, Fla., Aug. 1 ... Leonhardt, Chairman and CEO of,Bioheart, will present a corporate ... the Red Chip Investor Conference at the Marriott,Marquis in ... will be,available via the internet by visiting and registering ...
... Monitoring and ... Diagnostic System, ... ), announced it has entered into a non-binding letter of,intent ... a real-time wireless beat-to-beat, intelligent heart monitor and,diagnostic system, designed ...
... Holdings, a newly-formed,holding company that is the parent ... Diagnostics (CMDx), announced today that George Poste,D.V.M., Ph.D, ... with,the company, serving as Non-Executive Vice Chairman and ... of CMDx. Dr. Poste has,been a Director of ...
Cached Biology Technology:Bioheart, Inc. to Present at Red Chip Investor Conference in New York 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 3Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 4Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 5Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics 2Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics 3
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- The Geneva Healthcare ... cardiac devices, has cut emergency room wait times by ... Diego (UCSD) Medical Center, according to a recent study ... Emergency Departments are using the suite to access data ... or defibrillators. "Using Geneva,s technology platform we ...
(Date:7/24/2014)... (July 24, 2014) Scientists at The New ... one step closer to creating a viable cell ... own cells. , For the first time, ... lines from skin samples of patients with primary ... accelerated protocol to induce these stem cells into ...
(Date:7/24/2014)... animal species for food or commercial food sale, has ... the decline of many species of primates and other ... than half of the species being consumed are birds, ... not only the meat made available for sale but ... by hunters and brought to villages for consumption, we ...
Breaking Biology News(10 mins):UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... Delhi, IndiaThe Government of India,s Department of Biotechnology (DBT) ... III clinical trial of a rotavirus vaccine developed and ... at the International Symposium on Rotavirus Vaccines for IndiaThe ... excellent safety and efficacy profile. The clinical ...
... China, Australia and Japan today reports having sequenced and annotated ... have a powerful genetic system that repairs genetic defects, and ... than 86 percent of the nearly 27,000 genes of the ... and elsewhere as a symbol of spiritual purity and longevity. ...
... Ohio A study has identified microRNA-155 as a ... with acute myeloid leukemia that has normal-looking chromosomes under ... or CN-AML)., The study was led by researchers at ... G. James Cancer Hospital and Richard J. Solove Research ...
Cached Biology News:Rotavirus vaccine developed in India demonstrates strong efficacy 2Rotavirus vaccine developed in India demonstrates strong efficacy 3Rotavirus vaccine developed in India demonstrates strong efficacy 4Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 2Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 3Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 4Study identifies possible new acute leukemia marker, treatment target 2